Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: DrugBank:EXPT01586 (
G418
)
2,237
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In order to construct the recombinant retrovirus vector of human
ngn3
gene and its packaging cell line, we successfully amplified the open reading frame (ORF) of
ngn3
gene from human fetal pancreatic tissue by RT-PCR. The PCR products of human
ngn3
gene was subcloned into pMD18-T vectors and sequenced. Results showed that its sequence was fully consistent with the
ngn3
gene published in GenBank(GenBank Accession No. BC126468). The correct fragment was digested by EcoR I and Hpa I from recombinant pMD18-T vector and inserted into the same restriction enzyme sites of retroviral vector pMSCV-neo. We got recombinant retrovirus vector pMSCV-
ngn3
, which was identified by double restriction enzyme digestion and then transfected into PT67 cells by lipofectamine 2000. We established the PT67-
ngn3
packaging cell line by
G418
selection, which was detected by RT-PCR and immunohistochemistry staining. The detection results showed that the Ngn3 expressed at the mRNA and protein level in the packaging cell line. RT-PCR detection and electronic microscope analysis showed that the recombinant retroviral vector pMSCV-
ngn3
was packaged into infectious virus particles and released into the supernatant of the cells. These results demonstrated that a PT67-
ngn3
packaging cell line was successfully established, and this could facilitate the study of differentiation of the human fetal pancreatic progenitor cells into insulin-producing cells by using the
ngn3
gene.
...
PMID:[Construction and identification of recombinant retroviral vector of human ngn3 gene and its packaging cell line]. 2057 31